KAS
MBIO icon

Kestra Advisory Services’s Mustang Bio MBIO Stock Holding History

Kestra Advisory Services’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$128K Buy
176,042
+65,000
+59% +$61.2K ﹤0.01% 3002
2025
Q4 		$109K Buy
111,042
+44,934
+68% +$59.3K ﹤0.01% 3358
2025
Q3 		$100K Buy
+66,108
New +$118K ﹤0.01% 2819

Other funds holding MBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CG
CFO4Life Group Coppell, Texas $656M AUM 17.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Kestra Advisory Services's MBIO Position: Q1 2026 in Review

Kestra Advisory Services increased its Mustang Bio (MBIO) stake by 59% in Q1 2026, buying an estimated $61.2K and bringing the position to 176,042 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #3002.

Kestra Advisory Services first reported a position in MBIO in Q3 2025 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.

  • Kestra Advisory Services held 176,042 shares of Mustang Bio worth $128K as of Q1 2026.
  • Kestra Advisory Services bought 65,000 Mustang Bio shares in Q1 2026, an estimated $61.2K.
  • Mustang Bio made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #3002 holding.
  • Kestra Advisory Services first reported a position in Mustang Bio in Q3 2025 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.